LFST · LifeStance Health Group, Inc.
$13.07
+0.58% last session
End-of-day data · close of 2026-09-11
Market cap
$5B
Enterprise value
$5B
Trailing P/E
100.0
Forward P/E
24.5
Dividend yield
—
Beta
1.22
Avg volume
4M
Employees
9K
Daily Change %
0.58%
5 Days Change
-0.86%
10 Days Change
2.10%
30 Days Change
9.74%
60 Days Change
17.89%
Month to Day Change
0.16%
Year to Day Change
79.26%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — LFST
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-09-10
Latest call per bank · past 12 months
Barclays
Overweight$15.00
+15.4% vs priceJP Morgan
Neutral$13.00
+0.0% vs priceGoldman Sachs
Neutral$9.00
-30.8% vs priceUBS
Buy$12.00
-7.7% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-10 | Barclays | Maintains | Overweight | $13.00 → $15.00 |
| 2026-09-09 | Canaccord Genuity | Maintains | Buy | $13.00 → $15.00 |
| 2026-08-19 | BTIG | Maintains | Buy | $16.00 → $18.00 |
| 2026-08-14 | JP Morgan | Maintains | Neutral | $9.00 → $13.00 |
| 2026-08-07 | BTIG | Maintains | Buy | $15.00 → $16.00 |
| 2026-07-24 | BTIG | Maintains | Buy | $12.00 → $15.00 |
| 2026-07-21 | Canaccord Genuity | Maintains | Buy | $11.00 → $13.00 |
| 2026-07-14 | Barclays | Maintains | Overweight | $9.00 → $13.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 66 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 12.2% above the 50-day MA ($11.65).
- Price vs 200-day MA: Trading 56.2% above the 200-day MA ($8.37).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.01) — short-term momentum is fading.
- 52-week range: Price is within 5% of the 52-week high ($13.07).
LFST Price Chart
Loading chart for LFST…
Fundamentals
About LifeStance Health Group, Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
More in Medical Care Facilities
HCA
HCA Healthcare, Inc.
$93B -9.3% YTD
THC
Tenet Healthcare Corporation
$21B 35.4% YTD
FMS
Fresenius Medical Care AG
$12B -2.5% YTD
EHC
Encompass Health Corporation
$12B 15.1% YTD
DVA
DaVita Inc.
$12B 61.1% YTD
UHS
Universal Health Services, Inc.
$10B -19.1% YTD
ENSG
The Ensign Group, Inc.
$10B -1.3% YTD
CHE
Chemed Corp
$7B 21.7% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.